Syntal Capital Partners’s MEDTOX SCIENTIFIC INC(NEW) MTOX Stock Holding History
Bought
Maintained
Sold
Syntal Capital Partners's MTOX Position: Q2 2014 in Review
Syntal Capital Partners sold out of MEDTOX SCIENTIFIC INC(NEW) (MTOX) in Q2 2014, closing a stake of 650 shares — an estimated $17 sold.
Syntal Capital Partners first reported a position in MTOX in Q1 2014 and held it in 1 quarter. The position peaked at $17 in Q1 2014. 0 funds tracked by Wall St. Rank hold MTOX as of Q2 2014.
- Syntal Capital Partners reported no remaining MEDTOX SCIENTIFIC INC(NEW) position as of Q2 2014 after selling out during the quarter.
- Syntal Capital Partners sold 650 MEDTOX SCIENTIFIC INC(NEW) shares in Q2 2014, an estimated $17.
- Syntal Capital Partners first reported a position in MEDTOX SCIENTIFIC INC(NEW) in Q1 2014 and held it in 1 quarter.
- Syntal Capital Partners's MEDTOX SCIENTIFIC INC(NEW) position peaked at $17 in Q1 2014.
- 0 funds tracked by Wall St. Rank held MEDTOX SCIENTIFIC INC(NEW) as of Q2 2014.
Based on Syntal Capital Partners's 13F filing for Q2 2014, filed 14 Aug 2014.